Skip to main content
OpenTrials

Clinical trial condition

Retinal Diseases

Explore clinical trials studying Retinal Diseases. Study availability and eligibility vary by location and protocol.

241 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Retinal Diseases trial results

Completed

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

NCT04964089

Conditions
Eye Diseases, Eye Diseases, Hereditary, Macular Degeneration, +10 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Northwest Arkansas Retina Associates Springdale, Arkansas, United States
  • California Retina Consultants Bakersfield, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 66 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT04592419

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +16 more
Locations
  • Northwest Arkansas Retina Associates Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Vitreous Associates Beverly Hills, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 141 locations
View Trial Details
Completed

Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)

NCT04857996

Conditions
Diabetes Mellitus, Diabetic Macular Edema (DME), Endocrine System Diseases, +8 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • The Retina Partners Encino, California, United States
  • Salehi Retina Institute Inc. Huntington Beach, California, United States
View all 22 locations
View Trial Details
Completed

Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]

NCT04945772

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +14 more
Locations
  • Nanoscope Clinical Site Beverly Hills, California, United States
  • Nanoscope Clinical Site Pensacola, Florida, United States
  • Nanoscope Clinical Site Fargo, North Dakota, United States
  • Nanoscope Clinical Site Houston, Texas, United States
View Trial Details

Related conditions